Laith Jamal Abu-Raddad, PhD

Professor of Population Health Sciences

Epidemiology (Population Health Sciences)

Weill Cornell Medical College in Qatar

Contact & profiles

lja2002@qatar-med.cornell.edu

Appointments

Professor of Population Health SciencesPrimary
Population Health Sciences · 2020–

Past Appointments

Professor of Healthcare Policy and Research
Population Health Sciences · 2017–2020
Associate Professor of Healthcare Policy and Research
Population Health Sciences · 2014–2017
Associate Professor of Public Health
Population Health Sciences · 2012–2013

Show all 5

Assistant Professor of Public Health
Population Health Sciences · 2009–2011
Visiting Assistant Professor of Public Health
Population Health Sciences · 2008–2009

Centers

Clinical & Translational Science Center

Education

Ph.D., Physics
Florida State University, 2000
M.Sc., Physics
Miami University, 1994
B.Sc., Physics
University of Jordan (Jordan), 1992

Highlights

1
The New England journal of medicine · 2021
HSHiam Souheil Chemaitelly HAHanan Abdul Rahim AAAdeel Ajwad Butt RBRoberto Bertollini LJLaith Jamal Abu-Raddad
PMID: 34614327PMCID: PMC8522799DOISenior author676 citations
2
Nature medicine · 2021
HSHiam Souheil Chemaitelly JAJoel A Malek HAHanan Abdul Rahim AAAdeel Ajwad Butt+1 more →LJLaith Jamal Abu-Raddad
PMID: 34244681DOISenior author305 citations
3
The New England journal of medicine · 2022
LJLaith Jamal Abu-Raddad HSHiam Souheil Chemaitelly HAHanan Abdul Rahim AAAdeel Ajwad Butt RBRoberto Bertollini
PMID: 35263534PMCID: PMC8929389DOIFirst author320 citations

Publications

407

Funding

Active

2 grants

Sub-PI
Global and regional characterization of herpes simplex virus type 1 and 2 epidemiology and the population level impact of novel herpes vaccines: Quantitative assessments
Qatar National Research Fund · 2024–2027 · via Qatar University
ARG01-0524-230321
PI
ARG01-0522-230273: Advancing Analytical and Quantitative Understanding of Global and Regional Gonorrhea Epidemiology and Progress towards Elimination
Qatar National Research Fund · 2024–2027
ARG01-0522-230273

Completed grants (11)

Co-I
Integrated Disease Surveillance in the COVID-19 Era
Bill & Melinda Gates Foundation · 2022–2025
BMGF INV-047025
PI
Characterizing hepatitis C virus epidemiology in Qatar and the Middle East and North Africa: Screening strategies and the path to HCV elimination by 2030
Qatar National Research Fund · 2020–2024
NPRP12S-0216-190094
PI
Chlamydia Trachomatis, Neisseria Gonorrhea, and Trichomonas Vaginalis Screening and Treatment of Pregnant Syrian Refugee Women in Lebanon - Phase 2: expansion outside Beirut
American University of Beirut, Lebanon (AUB) · 2022–2023Contract
PI
Mode of Transmission Study (MoT) to analyze the distribution of new infections by mode of exposure
UNAIDS · 2022–2023Contract
2022-1285733
PI
Forecasting the Epidemiology and Disease Burden of Diabetes Mellitus in Qatar, Development of Screening Strategy, and Assessment of the Impact of Public Health Prevention Interventions
Qatar National Research Fund · 2018–2022
NPRP10-1208-160017
PI
Quantitative assessment of the transmission dynamics and critical drivers of key sexually transmitted infections in the Middle East and North Africa
Qatar University · 2020–2022
QU 193942-01
PI
Core services agreement for Biostatistics Core to provide services to University of Calgary in Qatar.
University of Calgary in Qatar · 2018–2021Contract
SA 183237-03
Sub-PI
Effective Public Policy for Improving Sexual Health of Migrants/Refugees
Wellcome Trust · 2017–2021 · via University College of London
UCL 183874-01
PI
Characterizing the HIV/AIDS Epidemics in the Middle East and North Africa: Systematic Reviews and Quantitative Assessments
Qatar National Research Fund · 2016–2020
NPRP 9-040-3-008
PI
Global estimates of Neisseria gonorrhoeae prevalence among infertile populations and infertility clinic attendees
World Health Organization · 2017–2018Contract
WHO 182964-01
PI
Quantifying the Adverse Impact of Rising Diabetes Prevalence on Tuberculosis Global Burden, and Estimating the Impact of Targeted Interventions on Tuberculosis Transmission
Qatar National Research Fund · 2015–2018
NPRP 7 - 627 - 3 - 167

News mentions

5 View all WCM news ↗

How SARS-CoV-2 Evolved Through the COVID Pandemic
February 6, 2025
A new study reveals how the SARS-CoV-2 virus evolved from initially prioritizing increased transmissibility to enhanced immune evasion after the Omicron variant emerged according to Weill Cornell Medicine-Qatar (WCM-Q) researchers.
Qatar Omicron-Wave Study Shows Slow Decline of Natural Immunity, Rapid Decline of Vaccine Immunity
June 15, 2022
A recent Pfizer or Moderna mRNA-vaccine booster provided good but temporary protection against infection by the SARS-CoV-2 omicron variant.
Boosters Highly Effective Against COVID-19 Hospitalization and Death
March 30, 2022
Booster doses of mRNA vaccines provided strong protection against hospitalization and death from COVID-19 in Qatar, though breakthrough SARS-CoV-2 infections were greater for the omicron variant compared with the delta variant, according to a study by investigators at Weill Cornell Medicine—Qatar.
In Brief: Growing HIV Epidemics Among Female Sex Workers and Male Clients in the Middle East and North Africa
July 23, 2019
HIV epidemics are emerging and growing among female sex workers and their male clients in multiple countries in the Middle East and North Africa, and few of these epidemics have already reached their peak.
Epidemic Proportions
January 16, 2019
Researchers at WCM–Qatar hope to help Qatar curb its looming diabetes crisis.

Mentoring

3 All publications with mentees →